IBDEI0AH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4377,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,4377,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,4377,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,4378,0)
 ;;=Z95.2^^30^271^23
 ;;^UTILITY(U,$J,358.3,4378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4378,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,4378,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,4378,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,4379,0)
 ;;=Z79.01^^30^271^16
 ;;^UTILITY(U,$J,358.3,4379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4379,1,3,0)
 ;;=3^Long Term (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,4379,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,4379,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,4380,0)
 ;;=Z79.02^^30^271^17
 ;;^UTILITY(U,$J,358.3,4380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4380,1,3,0)
 ;;=3^Long Term (Current) Use of Antithrombotics/Antiplatelets
 ;;^UTILITY(U,$J,358.3,4380,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,4380,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,4381,0)
 ;;=I10.^^30^271^15
 ;;^UTILITY(U,$J,358.3,4381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4381,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,4381,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,4381,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,4382,0)
 ;;=I25.9^^30^271^11
 ;;^UTILITY(U,$J,358.3,4382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4382,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,4382,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,4382,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,4383,0)
 ;;=F11.20^^30^272^2
 ;;^UTILITY(U,$J,358.3,4383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4383,1,3,0)
 ;;=3^Opioid Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,4383,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,4383,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,4384,0)
 ;;=M54.5^^30^272^1
 ;;^UTILITY(U,$J,358.3,4384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4384,1,3,0)
 ;;=3^Low Back Pain
 ;;^UTILITY(U,$J,358.3,4384,1,4,0)
 ;;=4^M54.5
 ;;^UTILITY(U,$J,358.3,4384,2)
 ;;=^5012311
 ;;^UTILITY(U,$J,358.3,4385,0)
 ;;=M19.90^^30^272^3
 ;;^UTILITY(U,$J,358.3,4385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4385,1,3,0)
 ;;=3^Osteoarthritis,Unspec Site
 ;;^UTILITY(U,$J,358.3,4385,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,4385,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,4386,0)
 ;;=F43.10^^30^273^6
 ;;^UTILITY(U,$J,358.3,4386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4386,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,4386,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,4386,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,4387,0)
 ;;=F43.12^^30^273^5
 ;;^UTILITY(U,$J,358.3,4387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4387,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,4387,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,4387,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,4388,0)
 ;;=F32.9^^30^273^3
 ;;^UTILITY(U,$J,358.3,4388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4388,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,4388,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,4388,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,4389,0)
 ;;=F41.9^^30^273^2
 ;;^UTILITY(U,$J,358.3,4389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4389,1,3,0)
 ;;=3^Anxiety Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,4389,1,4,0)
 ;;=4^F41.9
 ;;^UTILITY(U,$J,358.3,4389,2)
 ;;=^5003567
 ;;^UTILITY(U,$J,358.3,4390,0)
 ;;=F10.20^^30^273^1
 ;;^UTILITY(U,$J,358.3,4390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4390,1,3,0)
 ;;=3^Alcohol Dependence,Uncomp
 ;;^UTILITY(U,$J,358.3,4390,1,4,0)
 ;;=4^F10.20
 ;;^UTILITY(U,$J,358.3,4390,2)
 ;;=^5003081
